GE HealthCare Technologies (GEHC) Research & Development (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Research & Development came in at $323.0 million in Q2 2026, up 6.95% YoY from $302.0 million in Q2 2025, and down 6.38% on a QoQ basis from $345.0 million in Q1 2026.
GE HealthCare Technologies (GEHC) Research & Development (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 5 years of Research & Development data on file, last reported at $323.0 million in Q2 2026.
- Quarterly Research & Development rose 6.95% year-over-year to $323.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.3 billion (down 1.76% YoY) and the FY2025 annual result came in at $1.3 billion, down 3.89% from the prior year.
- Research & Development declined to $323.0 million in Q2 2026, from $345.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $345.0 million in Q1 2026 to a low of $238.0 million in Q1 2022.
- A 5-year average of $303.9 million and a median of $315.5 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development gained 23.85% — and 2025, when it decreased 7.65%.
- Tracing GEHC's Research & Development over 5 years: stood at $271.0 million in 2022, then increased by 16.24% to $315.0 million in 2023, then increased by 9.21% to $344.0 million in 2024, then dropped by 6.1% to $323.0 million in 2025, then changed by 0.0% to $323.0 million in 2026.
- The last three Research & Development figures came in at $323.0 million (Q2 2026), $345.0 million (Q1 2026), and $323.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.43 Bn | 19.02 Bn | 1.54 Bn | 104.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 323.00 Mn |
| Mar 31, 2026 | 345.00 Mn |
| Dec 31, 2025 | 323.00 Mn |
| Sep 30, 2025 | 292.00 Mn |
| Jun 30, 2025 | 302.00 Mn |
| Mar 31, 2025 | 344.00 Mn |
| Dec 31, 2024 | 344.00 Mn |
| Sep 30, 2024 | 316.00 Mn |
| Jun 30, 2024 | 327.00 Mn |
| Mar 31, 2024 | 324.00 Mn |
| Dec 31, 2023 | 315.00 Mn |
| Sep 30, 2023 | 322.00 Mn |
| Jun 30, 2023 | 298.00 Mn |
| Mar 31, 2023 | 270.00 Mn |
| Dec 31, 2022 | 271.00 Mn |
| Sep 30, 2022 | 260.00 Mn |
| Jun 30, 2022 | 257.00 Mn |
| Mar 31, 2022 | 238.00 Mn |